These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15042693)

  • 1. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Ammann RA
    Cancer; 2004 Apr; 100(7):1547; author reply 1547-8. PubMed ID: 15042693
    [No Abstract]   [Full Text] [Related]  

  • 2. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
    Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
    J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we finally ready for outpatient management of febrile neutropenia?
    Saini S; Rosoff PM
    Pediatr Blood Cancer; 2007 Nov; 49(6):765-6. PubMed ID: 17514730
    [No Abstract]   [Full Text] [Related]  

  • 8. Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?
    Ammann RA; Simon A; de Bont ES
    Pediatr Blood Cancer; 2005 Sep; 45(3):244-7. PubMed ID: 15747334
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceftriaxone in febrile neutropenia.
    Karthaus M; Cornely OA
    J Chemother; 2003 Jun; 15(3):211-9. PubMed ID: 12868545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of 315neutropenic febrile episodes in a cancer center].
    Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J
    Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
    Petrilli AS; Dantas LS; Campos MC; Tanaka C; Ginani VC; Seber A
    Med Pediatr Oncol; 2000 Feb; 34(2):87-91. PubMed ID: 10657866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic reviews and meta-analysis of febrile neutropenia.
    Paul M; Leibovici L
    Mayo Clin Proc; 2005 Sep; 80(9):1122-5. PubMed ID: 16178491
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides.
    Laoprasopwattana K; Pruekprasert P; Laosombat V; Wongchanchailert M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):595-606. PubMed ID: 18092250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient antimicrobial protocol for febrile neutropenia: a nonrandomized prospective trial using ceftriaxone, amikacin, and oral adjuvant agents.
    Sahu S; Bapna A; Pai SK; Nair CN; Kurkure PA; Advani SH
    Pediatr Hematol Oncol; 1997; 14(3):205-11. PubMed ID: 9185205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient management of febrile neutropenia in children with cancer.
    Holdsworth M; Hanrahan J; Albanese B; Frost J
    Paediatr Drugs; 2003; 5(7):443-55. PubMed ID: 12837117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies.
    Feld R; Paesmans M; Freifeld AG; Klastersky J; Pizzo PA; Rolston KV; Rubenstein E; Talcott JA; Walsh TJ; ;
    Clin Infect Dis; 2002 Dec; 35(12):1463-8. PubMed ID: 12471564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.
    Escalante CP; Rubenstein EB; Rolston KV
    Support Care Cancer; 1996 Sep; 4(5):358-63. PubMed ID: 8883229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Empiric antibiotic therapy of febrile neutropenias in cancer patients treated with chemotherapy: oral trial?].
    Blay JY
    Bull Cancer; 1999 Sep; 86(9):718-9. PubMed ID: 10576810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.